Skip to main content
. 2021 Jul 1;56(4):300–307. doi: 10.5152/TurkArchPediatr.2021.21010

Table 3.

Comparison of Post-ligation Clinical Features and Morbidity Between Groups

Group A (≥3 Treatment Cycles), n = 10 Group B (≤2 Treatment Cycles), n = 14 P
Post-ligation invasive MV duration (day), median (min–max) 18 (8-43) 15.5 (7-22) .196 U
Post-ligation non-invasive MV duration (day), median (min–max) 14.5 (5-28) * 15.5 (3-44) .494 U
Post-ligation oxygen therapy duration (day), median (min–max) 19.5 (6-22) * 20 ( 9-36) .607 U
Total (pre + post) invasive MV duration (day), median (min–max) 46 (28-79) 32 ( 24- 44) .004 U
Hospitalization time day, median (min–max) 100 (83-120)* 79 (56-129) .101 U
Postconceptional week at discharge, (mean ± SD) 40 ± 2* 38.9 ± 2.2 .248 t
Discharge weight, grams, (mean ± SD) 2563 ± 493* 2543 ± 594 .937 t
BPD χ2
 Mild 0 (0) 1 (7.1) .019
 Moderate 3 (30) 11 (78.6)
 Severe 7 (70) 2 (14.3)
ROP χ2
 no 1 (10) 1 (7.1)
 Stage 1 1 (10) 7 (50) .216
 Stage 2 5 (50) 3 (21.4)
 ≥Stage 3 3 (30) 3 (21.4)
PVL, n (%) 1 (10) 1 (7.1) .803 χ2
Mortality, n (%) 2 (20) 0 (0) .081 χ2

*Group A was evaluated by excluding patients with mortality results (n = 8).

MV, mechanical ventilation; BPD, bronchopulmonary dysplasia; ROP, retinopathy of prematurity; PVL, periventricular leucomalasia; χ 2 , chi-square test; t, independent samples t-test.